Viking Therapeutics ( VKTX -0.88%) soared early last year when it reported strong data from the phase 2 trial of its weight loss candidate, VK2735, but the stock has since given back those gains and …
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
view original post